News from Valensa International:
Valensa Announces Immunity-Enhancing Immunum™ Chewable Tablets
Triple action pre-workout and recovery breakthrough features two types of immune boosting ingredients along with Astaxanthin and Manuka Honey ORLANDO, Fla., Sept. 8, 2016 /PRNewswire/ — Valensa International announced today that it has initiated production and first deliveries of a pre- and post-workout immunity boosting and recovery chewable called Immunum™. Immunum contains 1,3 Beta Glucan […]
New Joint Health Chewable Supplement From Valensa
An Easy-to-Ingest "Full Spectrum" Alternative to Glucosamine/ Chondroitin Tablets ORLANDO, Fla., Aug. 9, 2016 /PRNewswire/ — Valensa International today announced the addition of Flex Pro ES™ Chewables to its Flex Pro family of joint health products. Flex Pro ES™ Chewables provide multiple modes of support for joint health, leveraging the benefits of Zanthin® Natural Astaxanthin, Flexuron™, […]
Valensa Pioneers Ecologically Sustainable Omega-3 Phospholipid Complex
Addresses the industry's demand for a differentiated EPA/DHA phospholipid supplement, fortified with ALA and Astaxanthin ORLANDO, Fla., May 13, 2016 /PRNewswire/ — Valensa International announced today that it has completed manufacturing ovo-vegetarian Deep Ocean Caviar™, a first-of-its-kind Omega-3 phospholipid supplement that contains no fish oil. Deep Ocean Caviar™ is derived from North Atlantic Herring Roe (herring […]
Valensa Awarded U.S. Patents on Omega-3 Perilla Seed Compositions
Major Use Patent Covers Perilla Seed Oil in Combination with Other Plant & Marine Omega-3s to Support Cardiovascular Health ORLANDO, Fla., Sept. 24, 2015 /PRNewswire/ — Valensa International announced today that it has received a series of patents covering the composition and application of nutraceutical formulations featuring Perilla seed oil as a major component. The […]
Valensa Introduces 1,3 Beta Glucan Targeting Immune Health Formulations
"Whole Algae" IMMUNUM™ PRO Considered the Most Efficacious Form of Beta Glucan for Immune Support ORLANDO, Fla., Sept. 30, 2014 /PRNewswire/ — Valensa International announced today that it will market and formulate a proprietary, new form of beta glucan for the human health market. Called IMMUNUM™ PRO, the new ingredient is a harvested Euglena algae […]
Valensa Is Granted New Patents for "Worry Free" Chia-based Ingredients
Manufacturing and Composition of Matter IP Demonstrates Significant Advances in Processing Technology Allowing for High Nutritional Content and Safe End Products ORLANDO, Fla., July 1, 2014 /PRNewswire/ — Valensa International, an early pioneer in the production of Chia Omega-3 oil and Chia flour announced that it has been granted a series of patents on its chia […]
Valensa Introduces Flex Pro ES™ Astaxanthin Gummy for Joint Health
Advanced Formula Brings Together Astaxanthin Plus 3 Ingredients for Joint Support ORLANDO, Fla., May 6, 2014 /PRNewswire/ — Valensa International announced that it has launched and is shipping a new joint health gummy based on its existing Flex Pro ES™ joint health product, previously only available in capsules. Flex Pro ES Gummy was developed to provide […]
Valensa Parent EID Parry Acquires Astaxanthin Biomass Production Facility Alimtec SA
Chile-based Firm Will Expand and Devote 100% of Its Capacity to Valensa's Growing Human Health Products Lineup ORLANDO, Fla., April 28, 2014 /PRNewswire/ — Valensa International announced today that its parent company – EID Parry (Murugruppa Group, India) – has acquired Alimtec SA, a Chile-based company of the Bayer AG Group. The acquisition of Alimtec, […]
Valensa Announces Availability of ZanthinNEX® Astaxanthin in Q4 2014
"Nature-Equivalent" Material Will Offer Improved Quality and Bioavailability to Consumers and Help Industry Meet Burgeoning Demand ORLANDO, Fla., March 17, 2014 /PRNewswire/ — Valensa International announced today that it will begin to offer ZanthinNEX® Astaxanthin commercially in late 2014. ZanthinNEX is a form of the carotenoid Astaxanthin produced via a proprietary process using natural enzymatic conversions […]
Valensa Supplier Launches Major Expansion of Natural Astaxanthin Biomass Capacity
Algae Producer Contract Biotics to Add Six Additional Acres to Its Operations ORLANDO, Fla. and LA JOLLA, Calif., March 7, 2014 /PRNewswire/ — Valensa International and Contract Biotics announced today that Contract Biotics has started construction of an additional six acres of algae production units at the company's San Diego County facility. Slated to come […]
Valensa Receives Five US Patent Approvals on GoEasy™ Gastrointestinal Health Formula
New IP Covers Natural Promotion of Regularity and Improved Lipid Health via Reduction of the Cholesterol Re-Uptake Mechanism ORLANDO, Fla., March 7, 2013 /PRNewswire/ — Valensa announced today that it has received five new US patents on its GoEasy™ Gastrointestinal Health Formula. GoEasy Gastrointestinal Health Formula is a unique micro-dispersion of natural, plant-based, non-GMO policosanols in […]
Valensa Introduces Organic Spirulina "Minis" for Children & Seniors
Easy-to-swallow, Smaller 200 mg Dosage Size Continues Program to Broaden Consumer Acceptance of "Food of the Future" ORLANDO, Fla., March 6, 2013 /PRNewswire/ — Valensa International (Eustis, FL USA) announced today that it has introduced an easy-to-swallow, better tasting 200 mg dosage size of its Parry Organic Spirulina. Called Spirulina Minis, the new product continues the […]
Valensa Launches Broad New Portfolio of Perilla-based Formulations
Lineup Offers Ready Availability, Lower Cost, Superior ALA Omega-3 Content and Better Taste than Chia ORLANDO, Fla., March, 5, 2013 /PRNewswire/ — In response to consumer demand for plant-based Omega-3s and the global shortage of Chia seeds, Valensa International (Eustis, FL USA) announced today that it has launched a new portfolio of formulations based on the […]
Parry Organic Spirulina First to Receive FDA GRAS Status for Organic Spirulina Ingredient
Industry-Leading "Superfood" Also Gets Update to Achieve Mildest Taste of Any Organic Spirulina LAS VEGAS, Nov. 6, 2012 /PRNewswire/ — Valensa International (Eustis, FL USA) announced today that its Parry Organic Spirulina ingredient has received its "no objection" letter from the U.S. Food & Drug Administration (FDA) on its application for Generally Recognized as Safe (GRAS) […]
Parry Organic Spirulina First to Receive USP Dietary Ingredient Verification Program Certification
Market-leading "Superfood" Also First Spirulina Ingredient to Comply with Provisional USP Monograph for Spirulina EUSTIS, Fla., May 8, 2012 — Valensa International (Eustis, FL USA) announced today that its Parry Organic Spirulina Ingredient has been certified under the United States Pharmacopoeia Dietary Ingredient Verification Program (USP DIVP) and that Parry Nutraceuticals has earned the authorization […]
Valensa Introduces New 'Body Ready' Astaxanthin Formulation for Optimal Absorption
Zanthin® XP-3 Astaxanthin delivers nature's most powerful antioxidant via a plant-based delivery system that decreases dose while increasing absorption in a safe, effective formula ANAHEIM, Calif., March 7, 2011 — Valensa International (Eustis, FL USA) announced today that it has launched a new Astaxanthin formulation that is designed to provide optimal absorption in support of […]
EID Parry Completes Acquisition of Valensa International
Producer of Astaxanthin, Premium Nutraceutical Ingredients & Formulations Poised for Growth LAS VEGAS, Oct. 11, 2011 — E.I.D.-Parry (India) Limited, the bioproducts and nutraceutical division of the Murugappa Group, has announced the acquisition of 100% of the voting shares of U. S. Nutraceuticals LLC (dba Valensa International). Valensa will continue to operate as a Limited […]
Valensa Launches Go Easy™ for Improved Gastrointestinal Health in a 'Fast Food' World
New, Patented Policosanol Micro-dispersion Provides Plant-Wax and Omega-3 Fatty Acids to Assist More Frequent, Comfortable Regularity ANAHEIM, Calif., March 10, 2011 — In yet another product designed to combat the effects of the "fast food lifestyle" on consumers, Valensa International (Eustis, FL USA) announced a new, patented formulation that combines the natural effects of plant-based […]
Mercola Health Resources and Valensa International Announce Innovative, Good-Tasting Spirulina and Astaxanthin Tablet
Pur-Blue™ SpiruZan® – a combination of good nutrition and antioxidants in a 500 mg tablet – will be offered on the mercola.com website ANAHEIM, Calif., March 9, 2011 — Valensa International (Eustis, FL USA) and Mercola Health Resources, LLC (Hoffman Estates, IL) have entered into a license and supply agreement that provides Mercola Health Resources […]
Valensa Launches Omega Joe(TM) ALA as a Daily Source of Plant-Based ALA Omega-3
Super Critical DeepExtract(R) of Perilla Responds to Research Showing ALA Supplementation Offers Solid Support for Cardiovascular Health and Overall Well-Being LAS VEGAS, Oct. 22, 2010 — Valensa International (Eustis, FL USA) announced today that it has launched a new high-quality, supercritical CO2 extract of perilla as part of its expanding line of Omega-3 ingredients. Called […]
Valensa and Mercola Health Resources Announce Innovative Joint Health Product
New Flex Pro ES(TM) – a proprietary one-a-day four-component joint health formulation – will be offered on the mercola.com website ORLANDO, Fla., Oct. 20, 2010 — Valensa International (Eustis, FL USA) and Mercola Health Resources, LLC (Hoffman Estates, IL) announced today that they have entered into a license and supply agreement that provides Mercola Health […]
Leading Saw Palmetto Producer Reports That Consumers May Be Using Saw Palmetto Incorrectly in Support of Prostate Health
Confusion Between Powder Capsule and Extract Softgel Forms Can Result in Significant Under-dosing Relative to Clinical Trial Results ORLANDO, Fla., Aug. 10, 2010 — Today, Valensa International (Eustis, FL USA) sent communications to thought leaders, marketers and retailers of saw palmetto cautioning them about widespread improper use of the leading botanical ingredient in support of […]
Valensa Launches Eye Pro MD(TM) Eye Health Formula at Vitafoods 2010
New Eye Health Supplement Based on CARMIS Studies Features Leading Eye Health Support Ingredients in a Novel Delivery System GENEVA, May 20, 2010 — Valensa International (Eustis, FL USA) announced the introduction of a new eye health formulation that combines the leading eye health ingredients in a single, easy-to-use product. Called Eye Pro MD, the […]
Valensa Recognized by Frost & Sullivan for Leadership in Nutritional Eye Health Market
Company Awarded 2009 North American Frost & Sullivan Award for Customer Value Enhancement for Work in Eye Health ORLANDO, Fla., May 4, 2010 — Valensa International (Eustis, Fla.) is the recipient of a 2009 North American Frost & Sullivan Award for Customer Value Enhancement for its work in developing the global eye health market. Based […]
Valensa Introduces Deep Ocean Krill(TM) Ingredient for Nutritional Supplement Market
Premium Krill Oil Ingredient Boosts Astaxanthin Content in a Guaranteed Shelf-Stable Product ORLANDO, Fla., March 2, 2010 — Valensa International announced today that it has launched a new premium krill oil ingredient that boosts natural astaxanthin levels found in krill oil in a product that offers a guaranteed shelf-life of two years. Called Deep Ocean […]
Valensa Granted Licenses for BiovaFlex(TM) Water-Soluble Egg Shell Membrane Ingredient
Agreement Will Allow Valensa to Introduce State-of-the-Art Joint Health Formulations Featuring High Efficacy and Smaller Pill Sizes ORLANDO, Fla., Feb. 18, 2010 — Valensa International (Eustis, FL USA) announced today that it has entered into a license agreement with Biova, LLC (Johnston, Iowa USA) that will allow Valensa to include the patented BiovaFlex(TM) water-soluble egg […]
Valensa Teams with Aker BioMarine on Superba(TM) Krill Oil-Based Formulations for Joint Health and Eye Health Dietary Supplements
Exclusive Worldwide Agreement Will Allow Valensa to Develop Next-Generation Omega-3 Condition-Specific Formulations ORLANDO, Fla., Dec. 8, 2009 — Valensa International (Eustis, FL USA) announced today that it has reached an exclusive agreement with Aker BioMarine ASA (Oslo, Norway) to use Aker BioMarine's Superba(R) krill oil in condition-specific dietary supplement formulas targeting joint health and eye […]
Valensa Begins Licensing Patent for Astaxanthin in Eye Health Management
Zanthin(R) Natural Astaxanthin Has Excellent Market Potential for Baby Boomers and Other Consumers ORLANDO, Fla., Oct. 8, 2009 — Valensa International (Orlando, FL USA) announced today that it has initiated a broad out licensing effort for University of Illinois patent (US 5,527,533 and its foreign equivalents) for the use of the astaxanthin in eye healthcare […]
Valensa to Market Neptune Krill Oil NKO® Formulations for Joint Health and Eye Health Dietary Supplements
Exclusive Worldwide License Agreement with Neptune Technologies Will Allow Florida-based Developer of Specialty Supplements to Incorporate Omega-3 Phospholipid in Next-Generation Condition-Specific Formulations ORLANDO, Fla., Oct. 6, 2009 — Valensa International (Eustis, FL USA) announced today that it has reached agreement with Neptune Technologies & Bioressources Inc. (Laval, Quebec, CANADA) for an exclusive, worldwide license to […]
Astaxanthin Stability Breakthrough Achieved by Valensa
O2B(R) Peroxidation Blocker Technology and Supercritical CO2 Extraction Enable 4-Year Shelf Life for ZANTHIN(R) Natural Astaxanthin ORLANDO, Fla., Aug. 19, 2009 — Valensa International announced today that it has developed technology that has dramatically increased the stability and shelf-life of the powerful, versatile antioxidant astaxanthin. The company has just completed a 7-year shelf-life study of […]
Valensa Selects Parry Organic Spirulina as Ingredient of Choice for Premium Product Development
Excellent Phyto-Nutrient Profile, Organic Status and Low Metals Levels Cited as Key Reasons for Selection ORLANDO, Fla., June 17, 2009 — Valensa International has selected Parry Nutraceuticals' Organic Spirulina as the spirulina ingredient of choice for its range of new value-added nutrition products. Third-party laboratory analyses showed significantly higher levels of phyto-nutrients that consumers want […]
Valensa Completes Second Expansion of Astaxanthin Capacity
"Made in USA" label and allergen-free status of extracted product driving demand ORLANDO, Fla., April 14, 2009 — Valensa International announced that it has completed a second round of expansion for astaxanthin production at its Eustis, Florida facility. The move was made in light of growing demand for a high-quality astaxanthin from North America that […]
Valensa International's Dr. Rudi E. Moerck Appointed CEO
Pharmaceutical Industry Veteran Will Lead Company in Development of 'Next Generation' Dietary Supplements and Functional Food Ingredients ORLANDO, Fla., Feb. 19 2009 — Valensa International has appointed Dr. Rudi E. Moerck as President & Chief Executive Officer of the company. The move to add CEO duties for Dr. Moerck comes on the heels of Valensa's […]
Valensa International and Parry Nutraceuticals Join Forces in the Global Natural Products Marketplace
New Team Combines Botanical Material Sourcing, Formulation, Product Development and Marketing Expertise to Deliver the Next Generation of Products for Health and Nutrition ORLANDO, Fla., Nov. 26, 2008 — Valensa International (Orlando, USA) and Parry Nutraceuticals (Division of E.I.D. Parry (India) Ltd., Chennai, India), as part of a growth strategy for both companies, have joined […]
Valensa and Parry Nutraceuticals Introduce Organic SpiruZan(TM) Spirulina/Astaxanthin Complex as 'Lifestyle Support' for a Fast-Paced World
Synergistic formulation of SuperFood with Super Antioxidant provides 'brain+body' protection from dietary and environmental stress ORLANDO, Fla., Oct, 21, 2008 — Valensa International (Orlando, USA) and Parry Nutraceuticals (Chennai, India) are jointly introducing a new organic dietary supplement called SpiruZan(TM) – a synergistic complex of organic spirulina and astaxanthin in a single tablet presentation. SpiruZan […]
Valensa Introduces Certified Organic Saw Palmetto Extract for Men's Health
Certified Organic Saw Palmetto Berries Extracted in Certified Organic Super Critical CO2 Extraction Facilities ORLANDO, Fla., May 6, 2008 — Valensa International has announced that it has introduced a certified organic grade of its USPlus(R) Prostate Formula – a patented, solvent-free, supercritical carbon dioxide extract (Patent # US 6,669,968 and US 6,319,524) that delivers the […]
Valensa Expands Astaxanthin Extraction Capacity
Growing Demand for High-Quality Finished Product that Meets Regulatory & Health Issues and New Strategic Alliance Create Conditions for Expansion ORLANDO, Fla., Feb. 14, 2008 — Valensa International announced today that it has increased its capacity for the extraction of Haematococcus pluvialis for the manufacture of finished all-natural astaxanthin. The move was made in light […]
Valensa Appoints Dennis Nagle as Vice President of Production
Veteran of Pharmaceutical and Specialty Chemical Industries to Direct Manufacturing of High-Quality Botanical Extracts ORLANDO, Fla., Aug. 17, 2006 — Valensa International has appointed Mr. Dennis Nagle as Vice President of Production for the company's manufacturing facilities located in Eustis, Florida. In a career that spans more than 25 years, Mr. Nagle has held senior […]
Valensa Appoints Dr. Rudi E. Moerck President
EUSTIS, Fla., May 23, 2006 — Valensa International has appointed Dr. Rudi E. Moerck as President. In his new role, Dr. Moerck will lead both the technology development and new product commercialization efforts for the company, which already offers innovative natural botanical-sourced products such as ZANTHIN(R) astaxanthin, USPlus Saw Palmetto, CRANBEROL(R) cranberry seed extract and […]
